|
"feng wl"的相關文件
顯示項目 1-8 / 8 (共1頁)
1
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2025-02 |
Durvalumab, tremelimumab, and platinum chemotherapy in EGFR mutation–positive NSCLC: An open-label Phase 2 trial (ILLUMINATE)
|
Lee, CK;Liao, BC;Subramaniam, S;Chiu, CH;Mersiades, AJ;Ho, CC;Brown, C;Lai, CL;Hughes, BGM;Yang, TY;O'Byrne, K;Luo, YH;Yip, S;Ho, CL;Bray, V;Su, WC;Moore, M;Feng, WL;Bai, YY;Ford, K;Cummins, MM;Stockler, MR;Solomon, BJ;John, T;Chih-Hsin Yang, J |
| 國家衛生研究院 |
2023-11 |
ILLUMINATE: Efficacy and safety of durvalumab-tremelimumab and chemotherapy in EGFR mutant NSCLC following progression on EGFR inhibitors
|
Lee, C;Liao, BC;Subramaniam, S;Chiu, CH;Mersiades, A;Ho, CC;Brown, C;Lai, CL;Hughes, BGM;Yang, TY;O'Byrne, K;Luo, YH;Yip, S;Ho, CL;Bray, V;Su, WC;Moore, M;Feng, WL;Bai, YY;Stockler, M;Solomon, B;John, T;Yang, JCH |
| 國家衛生研究院 |
2022 |
Distinct immunogenetic profiles of chronic lymphocytic leukemia in Asia: A Taiwan Cooperative Oncology Group Registry Study
|
Yao, CY;Agathangelidis, A;Chuang, SS;Tsou, HH;Feng, WL;Liu, TC;Chen, TY;Yu, YB;Yeh, SP;Yao, M;Wang, CC;Lin, J;Hwang, WL;Gau, JP;Chou, WC;Chao, TY;Lin, LI;Tien, HF;Ghia, P;Wu, SJ |
| 國家衛生研究院 |
2016-05 |
A decade of changes in family caregivers' preferences for life-sustaining treatments for terminally Ill cancer patients at end of life in the context of a family-oriented society
|
Tang, ST;Wen, FH;Liu, LN;Chiang, MC;Lee, SC;Chou, MC;Feng, WL;Lin, YC;Liu, IP;Kuo, YH;Chi, SC;Lee, KC |
| 國家衛生研究院 |
2014-07 |
Associations between accurate prognostic understanding and end-of-life care preferences and its correlates among Taiwanese terminally ill cancer patients surveyed in 2011–2012
|
Tang, ST;Liu, TW;Chow, JM;Chiu, CF;Hsieh, RK;Chen, CH;Liu, LN;Feng, WL |
| 臺北醫學大學 |
2014 |
Associations between accurate prognostic understanding and end-of-life care preferences and its correlates amongTaiwanese terminally ill cancer patients surveyed in2011–2012
|
Tang, ST;Liu, TW;Chow, JM;Chiu, CF;Hsieh, RK;Chen, CH;Liu, LN;Feng, WL |
| 國家衛生研究院 |
2005-10 |
Epidemiologic correlates of cervical human papillomavirus prevalence in women with abnormal pap smear tests: a Taiwan Cooperative Oncology Group (TCOG) study
|
Sun, CA; Hsiung, CA; Lai, CH; Chen, CA; Chou, CY; Ho, CM; Twu, NF; Feng, WL; Chuang, MH; Hsieh, CY; Chu, TY |
| 國立臺灣大學 |
2005-10 |
Epidemiologic correlates of cervical human papillomavirus prevalence in women with abnormal Pap smear tests: a Taiwan Cooperative Oncology Group (TCOG) study.
|
Sun, CA; Hsiung, CA; Lai, CH; Chen, CA; Chou, CY; Ho, CM; Twu, NF; Feng, WL; Chuang, MH; Hsieh, CY; Chu, TY. |
顯示項目 1-8 / 8 (共1頁)
1
每頁顯示[10|25|50]項目
|
